相关实验视频

Updated: Jun 7, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

在英国的ATMP临床试验

Rehma Chandaria¹, Philippa Rice¹, Daniel Baston¹

¹Cell and Gene Therapy Catapult, London, UK.

Regenerative medicine

|November 16, 2024

概括

英国的英国.

科学领域:

再生医学是一种再生医学.
生物技术是生物技术.
临床试验临床试验

背景情况:

英国高级治疗药物 (ATMP) 临床试验数据库跟踪ATMP开发的进展.
该年度数据库由CGT Catapult制作,以评估英国的ATMP环境.
本分析将英国在全球ATMP行业的发现置于背景.

研究的目的:

要突出来自2023年英国ATMP临床试验数据库的关键发现.
评估英国在全球ATMP临床开发领域的地位.
检查吸引ATMP开发人员到英国的举措.

主要方法:

我们对全球数据的临床试验数据库进行了有针对性的搜索.
试验得到了改进,只包括那些符合ATMP定义的研究产品.
每个试验在分析中都被计算一次,以确保准确性.

主要成果:

英国正在进行的ATMP临床试验数量保持稳定,与全球10%的下降不同.
大约80%的英国ATMP试验是商业赞助的.
有证据表明,英国的ATMP试验从早期到后期阶段的进展.

结论:

英国仍然对ATMP临床试验具有吸引力.
英国政府的投资,MHRA的监管支持和ATTC网络促进了积极的ATMP开发生态系统.
这些因素有助于为英国的ATMP开发人员提供支持的环境.

关键词:

临床试验临床试验是指临床试验.细胞治疗疗法细胞治疗疗法基因治疗的基因疗法有关法律/监管的法律/监管.组织工程是组织工程.

更多相关视频

Transcranial Pulse Stimulation for Alzheimer's Patients

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...